Education
About Us
Working with TipRanks
Follow Us
Solasia Pharma KK (JP:4597)
:4597
RESEARCH TOOLSreports
Total Valuation
Solasia Pharma KK has a market cap or net worth of €8.44B. The enterprise value is ¥6.68B.
Market Cap€8.44B
Enterprise Value¥6.68B
Share Statistics
Solasia Pharma KK has 241,609,010 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding241,609,010
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Solasia Pharma KK’s return on equity (ROE) is -1.68 and return on invested capital (ROIC) is -161.82%.
Return on Equity (ROE)-1.68
Return on Assets (ROA)-1.43
Return on Invested Capital (ROIC)-161.82%
Return on Capital Employed (ROCE)-1.67
Revenue Per Employee13.74M
Profits Per Employee-84.39M
Employee Count23
Asset Turnover0.23
Inventory Turnover1.02
Valuation Ratios
The current PE Ratio of Solasia Pharma KK is -3.68. Solasia Pharma KK’s PEG ratio is 0.25.
PE Ratio-3.68
PS Ratio0.00
PB Ratio2.80
Price to Fair Value6.18
Price to FCF-3.01
Price to Operating Cash Flow-3.59
PEG Ratio0.25
Income Statement
In the last 12 months, Solasia Pharma KK had revenue of 316.00M and earned -1.94B in profits. Earnings per share was -9.77.
Revenue316.00M
Gross Profit185.00M
Operating Income-1.95B
Pretax Income-1.96B
Net Income-1.94B
EBITDA-1.75B
Earnings Per Share (EPS)-9.77
Cash Flow
In the last 12 months, operating cash flow was -658.00M and capital expenditures -212.00M, giving a free cash flow of -870.00M billion.
Operating Cash Flow-658.00M
Free Cash Flow-870.00M
Free Cash Flow per Share-3.60
Dividends & Yields
Solasia Pharma KK pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.45
52-Week Price Change20.00%
50-Day Moving Average31.90
200-Day Moving Average38.28
Relative Strength Index (RSI)59.32
Average Volume (3m)8.45M
Important Dates
Solasia Pharma KK upcoming earnings date is Aug 13, 2025, TBA (Not Confirmed).
Last Earnings DateMay 14, 2025
Next Earnings DateAug 13, 2025
Ex-Dividend Date―
Financial Position
Solasia Pharma KK as a current ratio of 6.56, with Debt / Equity ratio of 1.39%
Current Ratio6.56
Quick Ratio5.90
Debt to Market Cap0.00
Net Debt to EBITDA0.49
Interest Coverage Ratio-390.20
Taxes
In the past 12 months, Solasia Pharma KK has paid -19.00M in taxes.
Income Tax-19.00M
Effective Tax Rate<0.01
Enterprise Valuation
Solasia Pharma KK EV to EBITDA ratio is -3.58, with an EV/FCF ratio of -6.08.
EV to Sales19.91
EV to EBITDA-3.58
EV to Free Cash Flow-6.08
EV to Operating Cash Flow-6.09
Balance Sheet
Solasia Pharma KK has €1.06B in cash and marketable securities with ¥17.00M in debt, giving a net cash position of -€1.05B billion.
Cash & Marketable Securities€1.06B
Total Debt¥17.00M
Net Cash-€1.05B
Net Cash Per Share-€4.34
Tangible Book Value Per Share€5.82
Margins
Gross margin is 60.62%, with operating margin of -617.41%, and net profit margin of -614.24%.
Gross Margin60.62%
Operating Margin-617.41%
Pretax Margin-620.57%
Net Profit Margin-614.24%
EBITDA Margin-555.38%
EBIT Margin-617.09%
Analyst Forecast
The average price target for Solasia Pharma KK is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-48.95%
EPS Growth Forecast-42.99%